Pharmaceutical Industry

Page 99 of 100

Your pharmacist called. You owe $1.3 trillion.
Features

Your pharmacist called. You owe $1.3 trillion.

By
November 20, 2014
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
International

Pfizer to pay up to $2 billion for cancer alliance with Germany’s Merck

By
November 17, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance

Allergan in talks with another bidder as it looks to thwart Valeant

By
November 6, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
Retail

CVS Health’s tobacco ban hits retail sales after one month

By
November 4, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
Leadership

Sanofi’s CEO ouster: A snowball of bad judgment calls

By
October 30, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
International

Sanofi fires CEO after profit warning on key drug

By
October 29, 2014
Google X goes teeny-tiny to diagnose disease at its earliest stages

Google X goes teeny-tiny to diagnose disease at its earliest stages

By
October 28, 2014
Pfizer’s sales beats expectations even as top drugs lose patent protections
Finance

Pfizer’s sales beats expectations even as top drugs lose patent protections

By
October 28, 2014
NIGERIA-HEALTH-DISEASE-EPIDEMIC-EBOLA-LIBERIA
International

Technical hurdles, not funding, could hinder race for Ebola vaccines

By
October 27, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance

Allergan firms up its profit as it continues to rebuff Valeant’s advances

By
October 27, 2014
Technology
Finance

Merck’s cost cutting pays off as results beat expectations

By
October 27, 2014
BRITAIN-PHARMACEUTICAL-GSK
International

GlaxoSmithKline moving forward with Ebola vaccine

By
October 22, 2014
Daniel Loeb urges Amgen to split into two companies
Finance

Daniel Loeb urges Amgen to split into two companies

By
October 21, 2014
Management
Leadership

The top 10 best-performing CEOs

By
October 17, 2014
77993380
International

End of the road for inversions? Abbvie drops $55 billion Shire bid

By
October 16, 2014

Most Popular